arrow
A

Anna Partyka

medical college
H指数:29
被引数:2,382

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fine-tuning 5-HT7 receptor selectivity, inverse agonism, and metabolic stability of new (aryloxy)ethyl-piperidines toward antidepressant and pro-cognitive properties

优化新型(芳氧基)乙基哌啶类化合物的5-HT7受体选择性、反向激动作用和代谢稳定性,以增强其抗抑郁和促认知特性。

2025-11-210
PRE
The first-in-class 1,3,5-triazine-derived dual 5-HT6R/FAAH modulators in search for potential drug against neurodegenerative diseases with cognitive impairment

第一类1,3,5-三嗪衍生的双5-HT6R/FAAH调节剂,用于寻找针对伴有认知障碍的神经退行性疾病的潜在药物

2025-08-050
OA
Correction: Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models

更正:化合物PZ-1262,一种Brexpiprazole的4-异喹啉磺酰胺类似物,在啮齿动物模型中产生潜在的抗抑郁、抗焦虑和促认知作用。

2025-05-300
PREAI
Procognitive Potential of Neuroprotective Triazine 5-HT6 Receptor Antagonists Tested on Chronic Activity In Vivo in Rats: Computer-Aided Insight into the Role of Chalcogen-Differences on the Pharmacological Profile

神经保护性三嗪类5-HT6受体拮抗剂的促认知潜力:通过计算机辅助研究在体大鼠慢性实验中硫族差异对药理学谱的作用

2025-02-280
OA
Simultaneous 5-HT1BR agonist/5-HT6R antagonist action as a potential treatment of Parkinson's disease and its comorbidities
2025-02-010
PRE
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer's Disease
2024-01-089
OAAI
Hydrophobicity modulation via the substituents at positions 2 and 4 of 1,3,5-triazine to enhance therapeutic ability against Alzheimer's disease for potent serotonin 5-HT6R agents
2023-11-011
OAAI
Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT6R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease
2023-11-018
OAAI
Hybrid molecules combining GABA-A and serotonin 5-HT6 receptors activity designed to tackle neuroinflammation associated with depression
2023-02-0110
PRE
Overcoming undesirable hERG affinity by incorporating fluorine atoms: A case of MAO-B inhibitors derived from 1 H-pyrrolo-[3,2-c] quinolines
2022-06-0113
OAAI
Multifunctional Arylsulfone and Arylsulfonamide-Based Ligands with Prominent Mood-Modulating Activity and Benign Safety Profile, Targeting Neuropsychiatric Symptoms of Dementia
2021-08-2613
OAAI